Making Prostate Cancer Cells More Immunogenic
Author Information
Author(s): Matthews E, Yang T, Janulis L, Goodwin S, Kundu S D, Karpus W J, Lee C
Primary Institution: Northwestern University Medical School
Hypothesis
Can reducing TGF-β1 production make non-immunogenic prostate cancer cells immunogenic?
Conclusion
Reducing TGF-β1 production in prostate cancer cells increases their immunogenicity.
Supporting Evidence
- TGF-β1 levels decreased significantly after transfection.
- The rate of cell proliferation increased 3–5-fold after TGF-β1 reduction.
- Tumor incidence was significantly lower in TGF-β1 antisense transfected cells in immunocompetent hosts.
Takeaway
Scientists found that by lowering a certain protein in prostate cancer cells, they could make these cells more recognizable to the immune system.
Methodology
The study involved transfecting a prostate cancer cell line with an antisense construct to reduce TGF-β1 and measuring tumor incidence in different host types.
Participant Demographics
Copenhagen rats and athymic nude rats were used as hosts for tumor injection.
Statistical Information
P-Value
≤ 0.05
Statistical Significance
p≤0.05
Digital Object Identifier (DOI)
Want to read the original?
Access the complete publication on the publisher's website